Type 1 diabetes: Pathogenesis and prevention

Department of Clinical Science at North Bristol, University of Bristol, UK.
Canadian Medical Association Journal (Impact Factor: 5.96). 08/2006; 175(2):165-70. DOI: 10.1503/cmaj.060244
Source: PubMed


Type 1 diabetes results from the autoimmune destruction of insulin-producing beta cells in the pancreas. Genetic and, as yet undefined, environmental factors act together to precipitate the disease. The excess mortality associated with the complications of type 1 diabetes and the increasing incidence of childhood type 1 diabetes emphasize the importance of therapeutic strategies to prevent this chronic disorder. Why is it considered that type 1 diabetes might be preventable? Different strands of diabetes research are coming together to suggest therapeutic targets. Islet cell autoantibody assays make it possible to accurately identify people at risk of future disease. In most cases, a long prodrome provides a window of opportunity to reverse the autoimmune process. Although no current "cure" exists, recent genetic data and preliminary trial results suggest T cells as a target for preventive strategies. Another potentially attainable target is induction of tolerance to the beta-cell proteins such as insulin that are inappropriately recognized. Other strategies involve beta-cell replacement, but currently there are insufficient donor cells available. This may be overcome as the processes controlling the differentiation of pancreatic and nonpancreatic progenitors as well as replication of existing islet beta cells are unravelled.

12 Reads
  • Source
    • "Type 1 diabetes mellitus (T1D) is an autoimmune disease characterized by beta cell destruction [1]. Its incidence has increased by ∼3% per year in children under the age of 5 and represents 10% of all the cases of diabetes [2]. In Mexico, the incidence of T1D among children under 19 years of age is 6.2 per 100,000 insured cases in the Instituto Mexicano del Seguro Social (IMSS), the largest social health care provider throughout the country [3]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Objective. To compare the serum concentration of IL-6, IL-10, TNF, IL-8, resistin, and adiponectin in type 1 diabetic patients with and without metabolic syndrome and to determine the cutoff point of the estimated glucose disposal rate that accurately differentiated these groups. Design. We conducted a cross-sectional evaluation of all patients in our type 1 diabetes clinic from January 2012 to January 2013. Patients were considered to have metabolic syndrome when they fulfilled the joint statement criteria and were evaluated for clinical, biochemical, and immunological features. Methods. We determined serum IL-6, IL-8, IL-10, and TNF with flow cytometry and adiponectin and resistin concentrations with enzyme linked immunosorbent assay in patients with and without metabolic syndrome. We also compared estimated glucose disposal rate between groups. Results. We tested 140 patients. Forty-four percent fulfilled the metabolic syndrome criteria (í µí±› = 61), 54% had central obesity, 30% had hypertriglyceridemia, 29% had hypoalphalipoproteinemia, and 19% had hypertension. We observed that resistin concentrations were higher in patients with MS. Conclusion. We found a high prevalence of MS in Mexican patients with T1D. The increased level of resistin may be related to the increased fat mass and could be involved in the development of insulin resistance.
    Journal of Diabetes Research 08/2015; 2015(2). DOI:10.1155/2015/972073 · 2.16 Impact Factor
  • Source
    • "To date the exact etiology of TIDM is yet to be fully elucidated and there is presently no known method of preventing this autoimmune induced metabolic syndrome from occurring, neither is there a method for arresting or reversing this condition. The multifactorial combination of autoimmune dysfunction, tissue hypoxia, and bio-chemical disruptions are all seen to be contributory factors for b-cell destruction and the consequential disruption to insulin secretion [1] [2] [3] [4]. Although considered an 0306-9877/Ó 2014 Elsevier Ltd. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Mononuclear invasion of Langerhans islet and the ensuing insulitis triggers signal-transduction for the autoimmune mediated pancreatic beta-cell (ß-cell) apoptosis that severely disrupts insulin production resulting in hyperglycemia associated with Type-1 diabetes (T1DM). Today extensive global research is being conducted to eliminate the need for insulin, and even prevent or find a cure for T1DM. The multifactorial combination of autoimmune dysfunction, Langerhans islet hypoxia, and bio-chemical disruption are seen to be contributory factors for ß-cell destruction and the consequential disruption to insulin production. Regeneration of ß-cells back to physiological levels may restore homeostatic insulin levels, reversing T1DM. Evidence suggests that there are still functioning pancreatic ß-cells even in long standing T1DM providing the potential for their regeneration. Although the exact mechanism of ESWT is yet to be fully elucidated, ESWT is seen to influence a complex spectrum of bio-chemical, cellular and neuronal functions (ie. suppression of pro-inflammatory immune response, improved tissue hemodynamics, anti-microbial properties and induction of progenitor cell expression including proangiogenic factors and nitric oxide syntheses). The rationale for the use of extracorporeal shockwaves (ESW) in this instance is attributed to its restorative properties and safety profile demonstrated in cardiology, chronic wounds, osteogenesis, complex pain syndromes, and tendinopathies. ESW may restore autoimmune homeostasis creating a suitable environment for pancreatic ß-cell proliferation that in-turn significantly increases or normalizes endogenous insulin secretion reducing or totally eliminating dependency of exogenous insulin. The devastating complications, morbidity and mortality associated with T1DM warrants the exploration of homeostatic autoimmune restorative treatment (HART) modalities that may partially or fully reverse this disease condition. We present our hypothesis discussing ESW as a potential homeostatic autoimmune restorative treatment (HART) option for T1DM.
    Medical Hypotheses 09/2014; 83(3). DOI:10.1016/j.mehy.2014.05.008 · 1.07 Impact Factor
  • Source
    • "The rapid increase in the incidence of type- 1 diabetes strongly suggests that the action of the environment on susceptibility genes contributes to the evolving epidemiology of type-1 diabetes (Gillespie, 2006). Liver is an insulin dependent tissue, which plays a pivotal role in glucose and lipid homeostasis and is severely affected during diabetes mellitus. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The purpose of this study was to investigate the effects of Commiphora mukul gum resin ethanolic extract (CMEEt) administration against altered activities of key enzymes of carbohydrate metabolism, lipid metabolism and changes in glycogen content (liver and muscle) and lipids (liver and heart) in streptozotocin (STZ) induced insulin deficient diabetic Wistar albino rats. Diabetes was induced by intraperitoneal injection of STZ (55 mg/kg body wt) to male Wistar rats. The animals were divided into four groups: Control (C), control-treated (C+CM), diabetic (D) and diabetic-treated group (D+CM). Diabetic-treated and control-treated rats were treated with C. mukul gum resin ethanolic extract (CMEEt) in 2 ml distilled water, orally (200 mg/kg body weight/day for 60 days). At the end of the experimental period, biochemical parameters related to carbohydrate and lipid metabolism were assayed. The significant enhancement in tissue lipids (heart and liver) total cholesterol, triglycerides, phospholipids and free fatty acids of diabetic rats were nearer to normalized in diabetic treated rats (D+CM). Alterations in the activities of enzymes of glucose metabolism (hexokinase, phosphofructokinase, pyruvate kinase, and glucose-6-phosphatase, fructose-1,6-bisphosphatase and glucose-6- phosphate dehydrogenase) and lipid metabolism (fatty acid synthase, malic enzyme and lipoprotein lipase) as observed in diabetic (D) rats were prevented with CMEEt administration. In conclusion, our findings indicate improvement of glucose and lipid metabolisms in STZ induced diabetic rats by treatment with Commiphora mukul and suggest that the plant can be used as an adjuvant for the prevention and/or management of insulin deficiency and disorder related to it. Keywords: C. mukul, diabetes, glycolysis, gluconeogenesis, lipogenesis, tissue lipids
    EXCLI Journal 06/2013; 12:556-568. · 0.86 Impact Factor
Show more


12 Reads
Available from